Nexgel (NXGL) Accumulated Expenses (2018 - 2025)

Nexgel (NXGL) reported Accumulated Expenses of $460000.0 for Q4 2025, up 48.39% on a YoY basis from $310000.0 in Q4 2024, and down 13.21% quarter-over-quarter from $530000.0 in Q3 2025.

Nexgel (NXGL) Accumulated Expenses (2018 - 2025) Analysis & Trends

Nexgel has reported Accumulated Expenses for 8 years, with the latest figure at $460000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses rose 48.39% year-over-year to $460000.0; the trailing twelve-month figure through Dec 2025 stood at $460000.0 (up 48.39% YoY), and the FY2025 full-year result was $460000.0, up 48.39% from the prior year.
  • Accumulated Expenses for Q4 2025 stood at $460000.0, down from $530000.0 in the prior quarter.
  • The five-year high for Accumulated Expenses was $609000.0 in Q3 2024, with the low at $48000.0 in Q3 2022.
  • Historically, Accumulated Expenses has averaged $220600.0 across 5 years, with a median of $121000.0 in 2022.
  • Annual changes were most pronounced in 2024 — Accumulated Expenses sank 51.49% — and 2025, when it surged 507.27%.
  • Nexgel's Accumulated Expenses stood at $62000.0 in 2021, then soared by 109.68% to $130000.0 in 2022, then surged by 206.15% to $398000.0 in 2023, then declined by 22.11% to $310000.0 in 2024, then jumped by 48.39% to $460000.0 in 2025.
  • The last three Accumulated Expenses figures came in at $460000.0 (Q4 2025), $530000.0 (Q3 2025), and $534000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn
10 Nexgel 4.18 Mn 2.81 Mn 819,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 460,000.00
Sep 30, 2025 530,000.00
Jun 30, 2025 534,000.00
Mar 31, 2025 334,000.00
Dec 31, 2024 310,000.00
Sep 30, 2024 609,000.00
Jun 30, 2024 98,000.00
Mar 31, 2024 55,000.00
Dec 31, 2023 398,000.00
Sep 30, 2023 152,000.00
Jun 30, 2023 202,000.00
Mar 31, 2023 112,000.00
Dec 31, 2022 130,000.00
Sep 30, 2022 48,000.00
Jun 30, 2022 85,000.00
Mar 31, 2022 57,000.00
Dec 31, 2021 62,000.00
Sep 30, 2021 77,000.00
Jun 30, 2021 70,000.00
Mar 31, 2021 89,000.00